AAAAAA

   
Results: 1-10 |
Results: 10
No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study
Authors: Vleggaar, FP van Buuren, HR Henegouwen, GPV Hop, WCJ van Erpecum, KJ
Citation: Fp. Vleggaar et al., No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study, EUR J GASTR, 13(2), 2001, pp. 171-175
Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant
Authors: Vleggaar, FP van Buuren, HR Zondervan, PE ten Kate, FJW Hop, WCJ
Citation: Fp. Vleggaar et al., Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant, GUT, 49(2), 2001, pp. 276-281
Management of osteoporosis in primary biliary cirrhosis
Authors: Wolfhagen, FHJ van Buuren, HR Vleggaar, FP Schalm, SW
Citation: Fhj. Wolfhagen et al., Management of osteoporosis in primary biliary cirrhosis, BEST PR RES, 14(4), 2000, pp. 629-641
High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis
Authors: van Buuren, HR van Hoogstraten, HJF Terkivatan, T Schalm, SW Vleggaar, FP
Citation: Hr. Van Buuren et al., High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis, J HEPATOL, 33(4), 2000, pp. 543-548
Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis
Authors: van den Hazel, SJ Wolfhagen, FHJ van Buuren, HR van de Meeberg, PC van Leeuwen, DJ
Citation: Sj. Van Den Hazel et al., Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis, ENDOSCOPY, 32(10), 2000, pp. 779-782
Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: A randomized double-blind pilot study
Authors: van Hoogstraten, HJF Vleggaar, FP Boland, GJ van Steenbergen, W Griffioen, P Hop, WCJ van Hattum, J Henegouwen, GPV Schalm, SW van Buuren, HR
Citation: Hjf. Van Hoogstraten et al., Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: A randomized double-blind pilot study, AM J GASTRO, 95(8), 2000, pp. 2015-2022
Prevention and treatment of osteoporosis in primary biliary cirrhosis
Authors: Vleggaar, FP van Buuren, HR Wolfhagen, FHJ Schalm, SW Pols, HAP
Citation: Fp. Vleggaar et al., Prevention and treatment of osteoporosis in primary biliary cirrhosis, EUR J GASTR, 11(6), 1999, pp. 617-621
Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis
Authors: van Hoogstraten, HJE Hansen, BE van Buuren, HR ten Kate, FJW van Berge-Henegouwen, GP Schalm, SW
Citation: Hje. Van Hoogstraten et al., Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis, J HEPATOL, 31(2), 1999, pp. 256-262
Sclerosing pancreato-cholangitis responsive to steroid therapy
Authors: Erkelens, GW Vieggaar, FP Lesterhuis, W van Buuren, HR van der Werf, SDJ
Citation: Gw. Erkelens et al., Sclerosing pancreato-cholangitis responsive to steroid therapy, LANCET, 354(9172), 1999, pp. 43-44
Upper gastrointestinal endoscopy at four intensive care units in one hospital: frequency and indication
Authors: Plaisier, PW van Buuren, HR Bruining, HA
Citation: Pw. Plaisier et al., Upper gastrointestinal endoscopy at four intensive care units in one hospital: frequency and indication, EUR J GASTR, 10(12), 1998, pp. 997-1000
Risultati: 1-10 |